Literature DB >> 26032405

Genetics of systemic sclerosis.

Lara Bossini-Castillo1, Elena López-Isac, Maureen D Mayes, Javier Martín.   

Abstract

Systemic sclerosis (SSc) is connective tissue disorder in which fibrosis of the skin and internal organs is the main hallmark. Despite the difficulties of studying a complex disease, significant advances have been achieved in the SSc genetics field. In this review, we will describe the firmest genetic susceptibility markers known to date. We will analyze the most recent findings in the HLA region and in non-HLA genes. Furthermore, we will propose functional connections of these loci with the mechanisms involved in SSc pathogenesis. However, only non-HLA genetic regions that have been associated with SSc at the genome-wide significance level or that have been reported to be associated with the disease in at least two different independent studies will be considered. In spite of the increasing number of SSc genetic susceptibility factors identified, further studies with larger sample sizes, deeper phenotype characterization of the patients and innovative analyses will be needed to translate SSc genetics into clinical practice and patient care in the future.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26032405     DOI: 10.1007/s00281-015-0499-z

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  83 in total

1.  A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations.

Authors:  Lara Bossini-Castillo; Jose-Ezequiel Martin; Jasper Broen; Olga Gorlova; Carmen P Simeón; Lorenzo Beretta; Madelon C Vonk; Jose Luis Callejas; Ivan Castellví; Patricia Carreira; Francisco José García-Hernández; Mónica Fernández Castro; Marieke J H Coenen; Gabriela Riemekasten; Torsten Witte; Nicolas Hunzelmann; Alexander Kreuter; Jörg H W Distler; Bobby P Koeleman; Alexandre E Voskuyl; Annemie J Schuerwegh; Øyvind Palm; Roger Hesselstrand; Annika Nordin; Paolo Airó; Claudio Lunardi; Raffaella Scorza; Paul Shiels; Jacob M van Laar; Ariane Herrick; Jane Worthington; Christopher Denton; Filemon K Tan; Frank C Arnett; Sandeep K Agarwal; Shervin Assassi; Carmen Fonseca; Maureen D Mayes; Timothy R D J Radstake; Javier Martin
Journal:  Hum Mol Genet       Date:  2011-11-10       Impact factor: 6.150

2.  Evaluation of all non-synonymous single nucleotide polymorphisms (SNPs) in the genes encoding human deoxyribonuclease I and I-like 3 as a functional SNP potentially implicated in autoimmunity.

Authors:  Misuzu Ueki; Kaori Kimura-Kataoka; Haruo Takeshita; Junko Fujihara; Reiko Iida; Rie Sano; Tamiko Nakajima; Yoshihiko Kominato; Yasuyuki Kawai; Toshihiro Yasuda
Journal:  FEBS J       Date:  2013-12-10       Impact factor: 5.542

Review 3.  The role of regulatory variation in complex traits and disease.

Authors:  Frank W Albert; Leonid Kruglyak
Journal:  Nat Rev Genet       Date:  2015-02-24       Impact factor: 53.242

4.  Targeting STAT4 in systemic sclerosis: a promising new direction.

Authors:  Jammie Barnes; Sandeep K Agarwal
Journal:  Expert Rev Clin Immunol       Date:  2011-07       Impact factor: 4.473

Review 5.  OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology.

Authors:  Naoto Ishii; Takeshi Takahashi; Pejman Soroosh; Kazuo Sugamura
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

6.  STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.

Authors:  P Dieudé; M Guedj; J Wipff; B Ruiz; E Hachulla; E Diot; B Granel; J Sibilia; K Tiev; L Mouthon; J L Cracowski; P H Carpentier; Z Amoura; I Fajardy; J Avouac; O Meyer; A Kahan; C Boileau; Y Allanore
Journal:  Arthritis Rheum       Date:  2009-08

Review 7.  Activation and function of interferon regulatory factor 5.

Authors:  Grigory Ryzhakov; Hayley L Eames; Irina A Udalova
Journal:  J Interferon Cytokine Res       Date:  2014-09-26       Impact factor: 2.607

Review 8.  Abnormal B lymphocyte activation and function in systemic sclerosis.

Authors:  Ayumi Yoshizaki; Shinichi Sato
Journal:  Ann Dermatol       Date:  2015-02-03       Impact factor: 1.444

9.  Autophagy and autoimmunity crosstalks.

Authors:  Abhisek Bhattacharya; N Tony Eissa
Journal:  Front Immunol       Date:  2013-04-15       Impact factor: 7.561

Review 10.  The role of type 1 interferon in systemic sclerosis.

Authors:  Minghua Wu; Shervin Assassi
Journal:  Front Immunol       Date:  2013-09-06       Impact factor: 7.561

View more
  10 in total

Review 1.  A Summary on the Genetics of Systemic Lupus Erythematosus, Rheumatoid Arthritis, Systemic Sclerosis, and Sjögren's Syndrome.

Authors:  Lourdes Ortíz-Fernández; Javier Martín; Marta E Alarcón-Riquelme
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-24       Impact factor: 8.667

Review 2.  Current advances in the treatment of systemic sclerosis.

Authors:  Heather Bukiri; Elizabeth R Volkmann
Journal:  Curr Opin Pharmacol       Date:  2022-04-18       Impact factor: 4.768

3.  Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations.

Authors:  Olga Y Gorlova; Yafang Li; Ivan Gorlov; Jun Ying; Wei V Chen; Shervin Assassi; John D Reveille; Frank C Arnett; Xiaodong Zhou; Lara Bossini-Castillo; Elena Lopez-Isac; Marialbert Acosta-Herrera; Peter K Gregersen; Annette T Lee; Virginia D Steen; Barri J Fessler; Dinesh Khanna; Elena Schiopu; Richard M Silver; Jerry A Molitor; Daniel E Furst; Suzanne Kafaja; Robert W Simms; Robert A Lafyatis; Patricia Carreira; Carmen Pilar Simeon; Ivan Castellvi; Emma Beltran; Norberto Ortego; Christopher I Amos; Javier Martin; Maureen D Mayes
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

Review 4.  Lung Involvements in Rheumatic Diseases: Update on the Epidemiology, Pathogenesis, Clinical Features, and Treatment.

Authors:  You-Jung Ha; Yun Jong Lee; Eun Ha Kang
Journal:  Biomed Res Int       Date:  2018-05-08       Impact factor: 3.411

Review 5.  Implication of oxidative stress in the pathogenesis of systemic sclerosis via inflammation, autoimmunity and fibrosis.

Authors:  Ludivine Doridot; Mohamed Jeljeli; Charlotte Chêne; Frédéric Batteux
Journal:  Redox Biol       Date:  2019-01-25       Impact factor: 11.799

Review 6.  Pathogenic Roles of Autoantibodies and Aberrant Epigenetic Regulation of Immune and Connective Tissue Cells in the Tissue Fibrosis of Patients with Systemic Sclerosis.

Authors:  Chang-Youh Tsai; Song-Chou Hsieh; Tsai-Hung Wu; Ko-Jen Li; Chieh-Yu Shen; Hsien-Tzung Liao; Cheng-Han Wu; Yu-Min Kuo; Cheng-Shiun Lu; Chia-Li Yu
Journal:  Int J Mol Sci       Date:  2020-04-27       Impact factor: 5.923

Review 7.  Role of NLRP3 inflammasome in systemic sclerosis.

Authors:  Cong Lin; Zhixing Jiang; Ling Cao; Hejian Zou; Xiaoxia Zhu
Journal:  Arthritis Res Ther       Date:  2022-08-16       Impact factor: 5.606

8.  A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator.

Authors:  Swati Bhattacharyya; Wenxia Wang; Lauren Van Duyn Graham; John Varga
Journal:  Arthritis Res Ther       Date:  2016-10-03       Impact factor: 5.156

9.  Screening and identification of biomarkers for systemic sclerosis via microarray technology.

Authors:  Chen Xu; Ling-Bing Meng; Yu-Chen Duan; Yong-Jing Cheng; Chun-Mei Zhang; Xing Zhou; Ci-Bo Huang
Journal:  Int J Mol Med       Date:  2019-09-05       Impact factor: 4.101

10.  PLG nanoparticles target fibroblasts and MARCO+ monocytes to reverse multiorgan fibrosis.

Authors:  Dan Xu; Swati Bhattacharyya; Wenxia Wang; Igal Ifergan; Ming-Yi Alice Chiang Wong; Daniele Procissi; Anjana Yeldandi; Swarna Bale; Roberta Goncalves Marangoni; Craig Horbinski; Stephen D Miller; John Varga
Journal:  JCI Insight       Date:  2022-03-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.